Nevertheless, recent studies have also suggested that Nkx2.1 is only expressed in lung adenocarcinoma, lung small cell cancer, and thyroid cancer, which highly supports that Nkx2.1 could be a potential biomarker for lung cancer diagnosis [13,14]. This evidence concerns the gene NKX2-1 and thyroid gland carcinoma.